Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients

References

• Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM, . Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 1992;112:891–6.
   PubMed Web of Science ®Google Scholar
• Povoski SP, Karpeh MS, Conlon KC, Blumgart LH, Brennan MF. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999;230:131–42.
   PubMed Web of Science ®Google Scholar
• Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002;236:17–27.
   PubMed Web of Science ®Google Scholar
• Nomura T, Shirai Y, Hatakeyama K. Impact of bactibilia on the development of postoperative abdominal septic complications in patients with malignant biliary obstruction. Int Surg 1999;84:204–8.
   PubMed Web of Science ®Google Scholar
• Parks RW, Halliday MI, McCrory DC, Erwin P, Smye M, Diamond T, . Host immune responses and intestinal permeability in patients with jaundice. Br J Surg 2003;90:239–45.
   PubMed Web of Science ®Google Scholar
• Akyürek N, Salman B, Irkörücü O, Tezcaner T, Azili C, Erdem O, . The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. J Invest Surg 2005;18:247–56.
   PubMed Web of Science ®Google Scholar
• Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T. Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996;83:1345–9.
   PubMed Web of Science ®Google Scholar
• Gurleyik E, Coskun O, Ustundag N, Ozturk E. Prostaglandin E1 maintains structural integrity of intestinal mucosa and prevents bacterial translocation during experimental obstructive jaundice. J Invest Surg 2006;19:283–9.
   PubMed Web of Science ®Google Scholar
• Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 2006;1072:242–52.
   PubMed Web of Science ®Google Scholar
• Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006;22:85–9.
   PubMed Web of Science ®Google Scholar
• Tsukita S, Furuse M. Occludin and Claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999;9:268–73.
   PubMed Web of Science ®Google Scholar
• Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000;118:1001–11.
   PubMed Web of Science ®Google Scholar
• Hossain Z, Hirata T. Molecular mechanism of intestinal permeability: interaction at tight junctions. Mol Biosyst 2008;4:1181–5.
   PubMed Web of Science ®Google Scholar
• Rao R, Basuroy S, Rao VU, Karnaky Jr KJ, Gupta A. Tyrosine phosphorylation and dissociation of Occludin, ZO-1 and E-cadherin gamma-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002;368:471–81.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos SF, Vagianos CE, Charonis AS, Alexandris IH, Spiliopoulou I, Thomopoulos KC, . Experimental obstructive jaundice alters Claudin-4 expression in intestinal mucosa: effect of bombesin and neurotensin. World J Gastroenterol 2006;12:3410–5.
   PubMed Web of Science ®Google Scholar
• Yang R, Harada T, Li J, Uchiyama T, Han Y, Englert JA, . Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 2005;31:709–17.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos SF, Scopa CD, Charonis A, Spiliopoulou I, Georgiou C, Nikolopoulou V, . Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering Occludin expression: beneficial effect of bombesin and neurotensin. J Am Coll Surg 2004;198:748–57.
   PubMed Web of Science ®Google Scholar
• Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low flow states. Arch Surg 1970;101:478–83.
   PubMedGoogle Scholar
• Inci K, Edebo A, Olbe L, Casselbrant A. Expression of protease-activated- receptor 2 (PAR-2) in human esophageal mucosa. Scand J Gastroenterol 2009;44:664–71.
   PubMed Web of Science ®Google Scholar
• Ma J, Li F, Liu L, Cui D, Wu X, Jiang X, . Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int 2009;29:567–74.
   PubMed Web of Science ®Google Scholar
• Kimmings AN, Van Deventer SJH, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000;46:725–31.
   PubMed Web of Science ®Google Scholar
• Yorganci K, Baykal A, Kologlu M, Saribaş Z, Hascelik G, Sayek I. Endotoxin challenge causes a proinflammatory state in obstructive jaundice. J Invest Surg 2004;17:119–26.
   PubMed Web of Science ®Google Scholar
• Ljungdahl M, Osterberg J, Ransjö U, Engstrand L, Haglund U. Inflammatory response in patients with malignant obstructive jaundice. Scand J Gastroenterol 2007;42:94–102.
   PubMed Web of Science ®Google Scholar
• Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991;19:785–91.
   PubMed Web of Science ®Google Scholar
• Parks RW, Stuart Cameron CH, Gannon CD. Changes in gastrointestinal morphology associated with obstructive jaundice. J Pathol 2000;192:526–32.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Georgiou CD, Scopa CD, Nikolopoulou VN, . Evidence for intestinal oxidative stress in patients with obstructive jaundice. Eur J Clin Invest 2006;36:181–7.
   PubMed Web of Science ®Google Scholar
• Dunnill MS, Whitehead R. A method for quantitation of small intestinal biopsy specimens. J Clin Pathol 1972;25:243–6.
   PubMed Web of Science ®Google Scholar
• Yüksek YN, Kologlu M, Daglar G, Doganay M, Dolapci I, Bilgihan A, . Intestinal ischemia-reperfusion injury augments intestinal mucosal injury and bacterial translocation in jaundiced rats. Hepatogastroenterology 2004;51:171–5.
   PubMedGoogle Scholar
• Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, . Heme oxygenase-1 induction by hemin protects against gut ischemia reperfusion injury. J Surg Res 2004;118:53–7.
   PubMed Web of Science ®Google Scholar
• Sakrak O, Kerem M, Bedirli A, Pasaoglu H, Akyurek N, Ofluoglu E, . Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury. J Surg Res 2008;144:36–42.
   PubMed Web of Science ®Google Scholar
• Nayci A, Atis S, Talas DU, Polat A, Bagdatoglu O, Polat G. Bronchoscopy induces intestinal mucosal barrier dysfunction: a possible role for nitric oxide. Int J Pediatr Otorhinolaryngol 2003;67:957–63.
   PubMed Web of Science ®Google Scholar
• Koivusalo A, Kauppinen H, Anttila A, Heikkilä P, Rintala R, Lindahl HJ. Rectosigmoid pHi monitoring during experimental necrotizing enterocolitis. Pediatr Surg 2000;35:1462–7.
   Google Scholar
• Pang Q, Ji Y, Li Y, Bermúdez-Humarán LG, Hu G, Zeng Y. Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats. FEMS Microbiol Lett 2008;283:62–8.
   PubMed Web of Science ®Google Scholar
• Yang ZW, Li JG, Mao XG, Sun B, Tong ZS, Sun HY, . Effects of recombinant human growth hormone on intestinal translocation of bacteria and endotoxin in rats with obstructive jaundice. Hepatobiliary Pancreat Dis Int 2005;4:445–9.
   PubMedGoogle Scholar
• Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol 2007;13:6458–64.
   PubMed Web of Science ®Google Scholar
• Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006;55:1512–20.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003;81:1–44.
   PubMed Web of Science ®Google Scholar
• Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, . Tight junctions are membrane microdomains. J Cell Sci 2000;113:1771–81.
   PubMed Web of Science ®Google Scholar
• Utech M, Brüwer M, Nusrat A. Tight junctions and cell-cell interactions. Methods Mol Biol 2006;341:185–95.
   PubMedGoogle Scholar
• Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: An interface between health and disease. J Gastroenterol Hepatol 2003;18:479–97.
   PubMed Web of Science ®Google Scholar
• Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124:3–20.
   PubMed Web of Science ®Google Scholar
• Tamagawa H, Takahashi I, Furuse M, Yoshitake-Kitano Y, Tsukita S, Ito T, . Characteristics of Claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of Claudin-4 at the apex of the dome region. Lab Invest 2003;83:1045–53.
   PubMed Web of Science ®Google Scholar
• Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002;131:241–4.
   PubMed Web of Science ®Google Scholar
• Ballinger AB, Woolley JA, Ahmed M, Mulcahy H, Alstead EM, Landon J, . Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 1998;42:555–9.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos SF, Mavrakis AG, Grintzalis K, Papapostolou I, Zervoudakis G, Konstantinou D, . Superoxide radical formation in diverse organs of rats with experimentally induced obstructive jaundice. Redox Rep 2008;13:179–84.
   PubMed Web of Science ®Google Scholar
• Ogata Y, Nishi M, Nakayama H, Kuwahara T, Ohnishi Y, Tashiro S. Role of bile in intestinal barrier function its inhibitory effect on bacterial translocation in obstructive jaundice in rats. J Surg Res 2003;115:18–23.
   PubMed Web of Science ®Google Scholar
• Aldemir M, Geyik MF, Kökoğlu OF, Büyükbayram H, Hoşoğlu S, Yağmur Y. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. ANZ J Surg 2003;73:722–6.
   PubMed Web of Science ®Google Scholar
• Sheen-Chen SM, Chen HS, Ho HT, Chen WJ, Sheen CC, Eng HL. Effect of bile acid replacement on endotoxin-induced tumor necrosis factor-alpha production in obstructive jaundice. World J Surg 2002;26:448–50.
   PubMed Web of Science ®Google Scholar
• Parks R. Gut barrier dysfunction in obstructive jaundice. The Purce Lecture 1997. Ulster Med J 1998;67 Suppl 1:86–90.
   PubMedGoogle Scholar
• Welsh FK, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, . Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 1998;227:205–12.
   PubMed Web of Science ®Google Scholar